Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021.
Date
2025-11
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Background
Comprehensive medication reviews (CMRs) are a cornerstone of medication therapy management (MTM) for millions of Medicare Part D beneficiaries, designed to optimize medication use and health outcomes. However, uptake is inconsistent, with known disparities affecting groups such as Asian, Black, and Hispanic patients.Objective
To evaluate CMR trends from 2013 to 2021, analyzing changes in provider types, delivery methods, and recipients, with a particular focus on variations across Asian, Black, Hispanic, and White beneficiaries.Methods
Employing a serial cross-sectional design, we analyzed Part D MTM program data submitted to the Centers for Medicare & Medicaid Services (CMS) from 2013 through 2021, covering all MTM-eligible Medicare beneficiaries. To explore differences based on race and ethnicity, this dataset was linked with a 5% random sample of Medicare fee-for-service beneficiaries. Descriptive statistics were used to evaluate year-over-year trends in CMR provider categories, the methods of service delivery, and the individuals who received the CMR.Results
The volume of completed CMRs expanded more than 4-fold, increasing from 526,150 encounters in 2013 to more than 2 million by 2020, before a slight decrease in 2021. The proportion of CMRs delivered by plan or pharmacy benefit manager pharmacists declined from 40% in 2013 to 29% in 2021, and the share of reviews provided by MTM vendors and other pharmacist categories generally increased over the same period. Telephone consultations, already the primary mode of delivery, increased their share from 86% to 96% of all CMRs, whereas face-to-face services correspondingly decreased from 14% to 4% across all racial groups. The decline in face-to-face services was steepest for Asian (from 18% in 2013 to 7% by 2021) and Hispanic patients (from 18% in 2013 to 3% by 2021). Black individuals consistently had the highest rates of direct beneficiary involvement (88% in 2021) and the lowest caregiver use.Conclusions
The substantial growth in CMR services represents a positive development in patient care. Nevertheless, the marked shifts toward telephonic delivery and changes in the types of providers and recipients engaged highlight a critical need for ongoing assessment.Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Shenoy, Devika A, Lauren Wilson, Joel Farley, Lynn DeGuzman, Margie Snyder, Antoinette B Coe, Lisa E Hines, Nicole Brandt, et al. (2025). Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021. Journal of managed care & specialty pharmacy, 31(11). pp. 1207–1216. 10.18553/jmcp.2025.31.11.1207 Retrieved from https://hdl.handle.net/10161/33871.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Anna Hung
Anna Hung, PharmD, PhD, MS is a pharmacist and health services researcher interested in payer and patient decision making related to pharmacy benefits. Previously, she collaborated with the Defense Health Agency to evaluate the budgetary impact of their antidiabetic drug formulary changes. She has also worked with a variety of managed care organizations to assess their drug utilization and clinical management programs. Her methodological research interests include health care cost evaluations, quasi-experimental study designs, and stated preference research.
Dr. Hung received her Doctor of Pharmacy, Master of Science, and Doctor of Philosophy from the University of Maryland. Her PhD is in pharmaceutical health services research, with concentrations in pharmacoeconomics, comparative effectiveness research, and patient-centered outcomes research. Prior to joining the Department of Population Health Sciences, she completed a post-doctoral fellowship at the Duke Clinical Research Institute and served as Co-Chief Fellow.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.
